These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37414535)

  • 21. Behavioural pathology in Alzheimer's disease with special reference to apolipoprotein E genotype.
    Gabryelewicz T; Religa D; Styczynska M; Peplonska B; Pfeffer A; Wasiak B; Luczywek E; Golebiowski M; Androsiuk W; Czyzewski K; Przekop I; Barcikowska M
    Dement Geriatr Cogn Disord; 2002; 14(4):208-12. PubMed ID: 12411763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Apolipoprotein E4 and Alzheimer's disease].
    Mori S
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():812-7. PubMed ID: 11347179
    [No Abstract]   [Full Text] [Related]  

  • 23. Apolipoprotein E and the neuropathology of Alzheimer's disease.
    Mirra SS
    Hum Pathol; 1999 Oct; 30(10):1125-7. PubMed ID: 10534156
    [No Abstract]   [Full Text] [Related]  

  • 24. About the use of APOE in Alzheimer's disease studies.
    Verpillat P; Margaritte-Jeannin P; Clerget-Darpoux F
    Am J Med Genet; 1998 Mar; 81(2):195. PubMed ID: 9613862
    [No Abstract]   [Full Text] [Related]  

  • 25. ApoE: new risk factor for Alzheimer's.
    Butler RN
    Geriatrics; 1994 Aug; 49(8):10-1. PubMed ID: 8039724
    [No Abstract]   [Full Text] [Related]  

  • 26. The -491AA polymorphism in the APOE gene is associated with increased plasma apoE levels in Alzheimer's disease.
    Laws SM; Taddei K; Martins G; Paton A; Fisher C; Clarnette R; Hallmayer J; Brooks WS; Gandy SE; Martins RN
    Neuroreport; 1999 Mar; 10(4):879-82. PubMed ID: 10208564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of apolipoprotein E genotype on biochemical markers of Alzheimer's disease.
    Schenk D; Lieberburg I; Motter R; Seubert P
    Ann N Y Acad Sci; 1996 Dec; 802():92-100. PubMed ID: 8993488
    [No Abstract]   [Full Text] [Related]  

  • 28. Factors Influencing Alzheimer's Disease Risk: Whether and How They are Related to the APOE Genotype.
    Zhang R; Xu X; Yu H; Xu X; Wang M; Le W
    Neurosci Bull; 2022 Jul; 38(7):809-819. PubMed ID: 35149974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experience of ApoE study in Thai elderly.
    Senanarong V; Harnphadungkit K; Lertrit P; Mitrpant C; Udompunthurak S; Limwong C; Prayoonwiwat N; Poungvarin N
    J Med Assoc Thai; 2001 Feb; 84(2):182-7. PubMed ID: 11336076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Apolipoprotein E genotypes in patients investigated for dementia].
    Johannsen P; Jakobsen JK; Jørgensen AL
    Ugeskr Laeger; 1997 Sep; 159(38):5658-61. PubMed ID: 9340872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. APOE genotype in the diagnosis of Alzheimer's disease in patients with cognitive impairment.
    Sun X; Nicholas J; Walker A; Wagner MT; Bachman D
    Am J Alzheimers Dis Other Demen; 2012 Aug; 27(5):315-20. PubMed ID: 22815080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lecanemab and APOE Genotyping in Clinical Practice-Navigating Uncharted Terrain.
    Thambisetty M; Howard R
    JAMA Neurol; 2023 May; 80(5):431-432. PubMed ID: 36912850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced cholinergic function in normal and Alzheimer's disease brain is associated with apolipoprotein E4 genotype.
    Allen SJ; MacGowan SH; Tyler S; Wilcock GK; Robertson AG; Holden PH; Smith SK; Dawbarn D
    Neurosci Lett; 1997 Dec; 239(1):33-6. PubMed ID: 9547165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apolipoprotein E genotype and Alzheimer's disease.
    Payami H; Kaye J; Heston LL; Bird TD; Schellenberg GD
    Lancet; 1993 Sep; 342(8873):738. PubMed ID: 8103834
    [No Abstract]   [Full Text] [Related]  

  • 35. ApoE-epsilon 4 and early-onset Alzheimer's.
    Okuizumi K; Onodera O; Tanaka H; Kobayashi H; Tsuji S; Takahashi H; Oyanagi K; Seki K; Tanaka M; Naruse S
    Nat Genet; 1994 May; 7(1):10-1. PubMed ID: 8075630
    [No Abstract]   [Full Text] [Related]  

  • 36. Apolipoprotein E-epsilon 4 allele and Alzheimer's disease.
    Anwar N; Lovestone S; Cheetham ME; Levy R; Powell JF
    Lancet; 1993 Nov; 342(8882):1308-9. PubMed ID: 7901622
    [No Abstract]   [Full Text] [Related]  

  • 37. Head injury and risk of Alzheimer's disease by apolipoprotein E genotype.
    O'Meara ES; Kukull WA; Sheppard L; Bowen JD; McCormick WC; Teri L; Pfanschmidt M; Thompson JD; Schellenberg GD; Larson EB
    Am J Epidemiol; 1997 Sep; 146(5):373-84. PubMed ID: 9290497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiological, clinical, and neuropathological study of apolipoprotein E genotype in Alzheimer's disease.
    Hyman BT; Gomez-Isla T; Rebeck GW; Briggs M; Chung H; West HL; Greenberg S; Mui S; Nichols S; Wallace R; Growdon JH
    Ann N Y Acad Sci; 1996 Dec; 802():1-5. PubMed ID: 8993478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and neuropathological correlates of apolipoprotein E genotype in Alzheimer's disease. Window on molecular epidemiology.
    Hyman BT; Gomez-Isla T; West H; Briggs M; Chung H; Growdon JH; Rebeck GW
    Ann N Y Acad Sci; 1996 Jan; 777():158-65. PubMed ID: 8624079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. No association between apolipoprotein E genotype and late-onset depression in Alzheimer's disease.
    Cantillon M; Harwood D; Barker W; St George-Hyslop P; Tsuda T; Ekatarina R; Duara R
    Biol Psychiatry; 1997 Jan; 41(2):246-8. PubMed ID: 9018400
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.